Journal
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY
Volume 12, Issue 2, Pages 109-117Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/17474124.2018.1412828
Keywords
Biopsy; non-endoscopic; minimally-invasive; esophagogastroduodenoscopy; gastrointestinal
Categories
Funding
- Bill and Melinda Gates Foundation [OPP1135172]
- Bill and Melinda Gates Foundation [OPP1135172] Funding Source: Bill and Melinda Gates Foundation
Ask authors/readers for more resources
Introduction: Diseases of the stomach and small intestine account for approximately 20% of all gastrointestinal (GI)-related mortality. Biopsy of the stomach and small intestine remains a key diagnostic tool for most of the major diseases that affect the GI tract. While endoscopic means for obtaining biopsy is generally the standard of care, it has several limitations that make it less ideal for pediatric patients and in low resource areas of the world. Therefore, non-endoscopic means for obtaining biopsy samples is of interest in these settings. Areas covered: We review non-endoscopic biopsy techniques reported thus far, and critically examine their merits and demerits regarding their suitability for obtaining biopsy samples in non-sedated subjects. Expert commentary: Esophagogastroduodenoscopy (EGD) is the current standard for acquiring biopsy from the GI tract, however, its limitations include subject sedation, expensive endoscopy infrastructure, expert personnel, and a small but significant risk of complications. A less costly, minimally-invasive and non-endoscopic means for obtaining biopsy samples is therefore of interest for addressing these issues. Such a technology would be of significant impact in low- and middle-income countries where conducting endoscopy is challenging.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available